Printer Friendly
The Free Library
14,558,467 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Hi-Tech Pharmacal to Release Second Quarter Earnings and Hold Conference Call on December 7, 2006.


AMITYVILLE, N.Y. -- Hi-Tech Pharmacal Co., Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: HITK) announced that the Company will release results for its second quarter of Fiscal Year 2007 ended October 31, 2006, prior to the market opening on Thursday December 7, 2006 and will hold a conference call to discuss its financial results at 10 a.m. Eastern Time.

To access the conference call, dial toll free 800-573-4752, or 617- 224-4324 for international callers, five minutes before the conference. The passcode of the conference call is 24265420.

A replay of the conference call will be available after 12 p.m. on December 7, 2006, for one week by calling toll free 888-286-8010, or 617-801-6888 for international callers. The passcode for the replay is 98810739.

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug.  and produces a range of sterile ophthalmic ophthalmic /oph·thal·mic/ (of-thal´mik) ocular (1).

oph·thal·mic
adj.
Of or relating to the eye; ocular.


Ophthalmic
Pertaining to the eye.
, otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 products for the diabetes marketplace.

Forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 (statements which are not historical facts) in this Press Release are made pursuant to the safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Forward-looking statements are not promises or guarantees and investors are cautioned that all forward-looking statements involve risks and uncertainties, including but not limited to the impact of competitive products and pricing, product demand and market acceptance, new product development, the regulatory environment, including without limitation, reliance on key strategic alliances, availability of raw materials, fluctuations in operating results and other results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. These statements are based on management's current expectations and are naturally subject to uncertainty and changes in circumstances. We caution you not to place undue reliance upon any such forward looking statements which speak only as of the date made. Hi-Tech is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 30, 2006
Words:357
Previous Article:ClearLab's AquaSoft Singles Honored in BRANDPACKAGING's 2007 Design Gallery.
Next Article:Fitch Withdraws Aames Investment Corp.'s Primary Servicer Rating for Subprime Product.
Topics:



Related Articles
Hi-Tech Pharmacal reports higher first quarter sales.
Hi-Tech Pharmacal to Release Second Quarter Earnings and Hold Conference Call on December 8, 2005.
Hi-Tech Pharmacal to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceutical Conference.
Hi-Tech Pharmacal to Present at the UBS Global Specialty Pharmaceuticals Conference.
Hi-Tech Pharmacal to Present at the FTN Midwest Securities Corp Health Care Conference.
Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 12, 2006.
Hi-Tech Pharmacal to Present at the Bank of America 2006 Specialty Pharmaceuticals Conference.
Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 7, 2006.
Hi-Tech Pharmacal to Present at the ThinkEquity 4th Annual Growth Conference.
Hi-Tech Pharmacal to Present at the CIBC World Markets 17th Annual Healthcare Conference.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles